epigallocatechin gallate has been researched along with Chronic Progressive Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuerda-Ballester, M; Drehmer, E; Ibáñez, V; Lopez-Rodríguez, MM; Ortí, JER; Platero, JL; Sancho, D | 1 |
| Bellmann-Strobl, J; Brandt, AU; Chien, C; Dörr, J; Klumbies, K; Lorenz, M; Paul, F; Rust, R; Scheel, M; Wernecke, KD; Wuerfel, J; Zimmermann, H | 1 |
2 trial(s) available for epigallocatechin gallate and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients.
Topics: Anxiety; Biomarkers; Body Mass Index; Catechin; Coconut Oil; Diet, Mediterranean; Dietary Supplements; Disability Evaluation; Emotions; Female; Humans; Interleukin-6; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects; Prospective Studies; Recovery of Function; Spain; Time Factors; Treatment Outcome | 2020 |
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.
Topics: Administration, Oral; Adult; Atrophy; Brain; Catechin; Disease Progression; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Outcome Assessment, Health Care; Random Allocation | 2021 |